In summary, CA-NPs alleviate the severity of acute pancreatitis through NLRP3 gene downregulation, and mitigate oxidative stress and inflammatory responses by inhibiting the NF-κB and ASK1/MAPK signaling pathways. The gene discussed is NLRP3; the disease is acute pancreatitis.